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ABSTRACT
We analyzed the effects of acute ischemia-reperfusion (KIR) injury on the status 
of kidney function and architecture in dipeptidyl peptidase4-difficient (DPP4D) rats and 
the effect of remote small bowel ischemia-reperfusion (BIR) preconditioning. DPP4-
deficient (DPP4D) and normal Fischer344 (F344) rats were divided into 6 groups: 
(1) sham-F344, (2) sham-DPP4D, (3) KIR-F344 (4) KIR-DPP4D, (5) DPP4D-KIR-
extendin-9-39 and (6) BIR-KIR-F344. Blood creatinine and urea nitrogen levels and 
the urinary protein-to-creatinine ratio was higher in KIR-F344 rats than BIR-KIR-F344 
or KIR-DPP4D rats 72 h after acute KIR. Conversely, the circulating glucagon-like 
peptide 1 (GLP-1) levels were higher in BIR-KIR-F344 and KIR-DPP4D than KIR-F344 
rats after acute KIR. KIR-F344 rats showed greater inflammation, oxidative stress, 
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INTRODUCTION
Despite novel drugs and improvements in critical 
care including renal replacement therapy, the outcomes for 
critically ill acute kidney injury (AKI) patients remains 
poor and its incidence during hospitalization keeps 
increasing [1–6]. Acute kidney ischemia-reperfusion 
(KIR) that causes AKI is frequently observed during 
contrast-media induced nephropathy [5], post-resuscitation 
shock [7], kidney transplantation [8] and chemical or 
drug toxicity. These result in acute tubular-epithelial 
damage [9, 10], loss of tubular microvasculature [11] and 
inflammation and leukocyte infiltration [8–10, 12]. 
 Acute KIR injury involves oxidative stress and 
reactive oxygen species (ROS) [13–15], mitochondrial 
damage [13–15], apoptosis [11, 13–15], and complement 
cascade and inflammation [11–15]. Therefore, suppression 
of inflammation and oxidative stress/ROS may be 
beneficial for AKI patients. 
Glucagon-like peptide-1 (GLP-1) based drugs 
are emerging therapeutics for type 2 diabetes mellitus 
(DM). GLP-1 reduces inflammation and oxidative stress/
ROS [14, 16–18] and the GLP-1 receptor (GLP-1R) is 
expressed in the brain, kidney, digestive organs and heart 
and upregulated during IR injury [14, 19–21]. Therefore, 
increased circulating levels of GLP-1 may protect the 
kidney from acute IR injury.
GLP-1 is the substrate of dipeptidyl peptidase 4 (DPP4) 
or CD26, which is a membrane-anchored ecto-protease 
that cleaves GLP-1. Hence, pharmacological inhibition of 
DPP4 enhances circulating GLP-1 levels [21–25] in animal 
models of acute kidney IR injury [14, 21, 23]. However, the 
direct association between DPP4 and GLP-1 has not been 
demonstrated, especially in regard to protection from acute 
IR injury [14, 15, 21, 24, 25].
The role of ischemic preconditioning in protecting 
organs from ischemic injury has been the focus of many 
investigations, especially related to the acute coronary 
syndrome [26–28].  Studies have shown that remote organ 
ischemia-related preconditioning protects other organs/
tissues against IR injury [29–31]. Especially, intestinal 
ischemic preconditioning suppresses oxidative stress and 
protects remote organs from ischemic reperfusion damage 
[32, 33]. These findings suggest that intermittent small 
bowel IR (BIR) may protect kidneys from acute IR injury 
since the gastro-intestinal tract secretes GLP-1 [26–33]. 
Therefore, in this study, we tested if DPP4 deficiency 
and intermittent BIR preconditioning protected kidneys 
against acute IR injury. 
RESULTS
Circulating creatinine and blood urea nitrogen 
(BUN) levels and urine protein to creatinine 
ratio at baseline and day 3 after acute KIR
Before the IR procedure, blood urea nitrogen (BUN) 
and blood creatinine were similar in all 6 groups of rats. 
Similarly, the protein to creatinine ratios in the urine 
was similar in the 6 groups of rats (Figure 1). However, 
72 h after acute KIR, blood creatinine and BUN levels 
that indicate renal dysfunction, and the urine protein to 
creatinine ratio that indicate glomerular damage were 
lowest in the SC-F344 and SC-DPP4D rats and gradually 
increased in BIR-KIR-F344, KIR-DPP4D, DPP4D-KIR- 
exendin-9-39 rats and were highest in KIR-F344 rats 
(Figure 1). 
Kidney injury score and circulating GLP-1 levels 
on day 3 after acute KIR 
We scored the H&E stained sections for kidney 
injury and found that SC-F344 and SC-DPP4D rats had 
lowest scores. The scores were gradually higher for BIR-
KIR-F344, KIR-DPP4D, DPP4D-KIR-exendin-(9-39) rats 
and were highest in KIR-F344 rats (Figure 2).
The baseline circulating levels of GLP-1 were 
higher in the SC-DPP4D rats than SC-F344 rats. Further, 
the circulating levels of GLP-1 on day 3 after acute KIR 
procedure were significantly lower in the SC-F344 than 
KIR-F344 and KIR-BIR-F344 group rats, which had 
similar GLP-1 levels. Circulating GLP-1 levels were 
higher in the KIR-DPP4D group and highest in KIR-
DPP4D + Ex4-9-39 group compared to the SC-DPP4D 
group. The higher circulating GLP-1 levels on day 3 after 
acute KIR in the KIR-DPP4D + Ex4-9-39 rats compared to 
KIR-BIR-F344 rats suggested enhanced intrinsic response 
to the occupied GLP-1R in kidney parenchyma elicited by 
Ex4-9-39 (Figure 2).
Time course analysis of circulating GLP-1 levels 
in BIR-KIR-344 and BIR-344 animals showed that they 
were markedly upregulated only at 3–6 h after BIR-KIR 
procedure suggesting that GLP-1 elevation was in 
response to IR (Figure 2).
apoptosis, DNA damage and kidney injury than other rat groups. Damage to the kidney 
architecture in KIR-F344 rats was greater than in BIR-KIR-F344 or KIR-DPP4D rats. 
Expression of antioxidant proteins and GLP-1 receptor was higher in kidneys from KIR-
DPP4D and BIR-KIR-F344 than KIR-F344 rats, which suggests better intrinsic responses. 
We therefore suggest that elevated circulating GLP-1 levels due to DPP4 deficiency and 
BIR preconditioning protect kidney function and architecture during acute IR injury.
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Figure 1: Blood urea nitrogen (BUN) and creatinine levels and urine protein to creatinine ratios at days 0 and 3 after 
acute KIR. (A, B) Circulating levels of blood urine nitrogen (BUN) at day 0 (p > 0.5) and day 3 after acute KIR in the 6 groups of rats. 
(C, D) Circulating level of creatinine at day 0 (p > 0.5) and day 3 after acute KIR in the 6 groups of rats. (E, F) Urine protein to creatinine 
ratio on day 0 (p > 0.5) and day 3 after acute KIR in the 6 groups of rats. Note: *denotes statistical significance vs. other groups with 
different symbols (†, ‡, §); p < 0.0001. All statistical analyses were performed by one-way ANOVA and Bonferroni multiple comparison 
post-hoc test (n = 8 for each group). Symbols (*, †, ‡, §) indicate statistical significance. SC = sham control; DPP4D = dipeptidyl peptidase 
4 deficient; BIR = small bowel ischemia-reperfusion; KIR = kidney ischemia-reperfusion.
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Status of inflammation, apoptosis and  
oxidative-stress on day 3 after acute KIR 
Further, we analyzed the status of inflammation 
in the 6 groups of mice by analyzing the expression of 
matrix metalloproteinase (MMP)-9, tumor necrosis factor 
(TNF)-α, nuclear factor (NF)-κB, interleukin (IL)-1β, 
intercellular adhesion molecule (ICAM)-1, and inducible 
nitric oxide synthase (iNOS). We observed that these six 
indicators of inflammation were lowest in SC-F344 and 
SC-DPP4D rats and gradually increased in BIR-KIR-F344, 
KIR-DPP4D, DPP4D-KIR- exendin-9-39 rats and were 
highest in KIR-F344 rats (Figure 3). 
A similar pattern was observed for the 3 apoptotic 
indicators, namely cleaved caspase 3, cleaved poly (ADP-
ribose) polymerase (c-PARP) and mitochondrial-Bax, and 
γ-H2AX that is a marker for DNA damage and NOX1, 
NOX2, and total oxidized protein that indicate oxidative 
stress (Figure 4).
Status of podocyte components, antioxidants and 
GLP-R on day 3 after acute KIR
We observed that zonula occludens 1 (ZO-1), a tight 
junction-associated protein in podocytes, and P-cadherin 
and E-cadherin, which are predominantly in renal 
glomerulus and endothelial nitric oxide synthase (eNOS), 
an indicator of endothelial function, vasorelaxation 
integrity and angiogenesis were high in SC-F344 and SC-
DPP4D rats and progressively lower in BIR-KIR-F344, 
KIR-DPP4D, DPP4D-KIR- exendin-9-39 rats and were 
lowest in KIR-F344 rats (Figure 5). The levels of GLP-1R 
and 3 antioxidant proteins, NQO 1, HO-1 and SOD-1 
progressively increased from groups 1–6 suggesting an 
intrinsic response to ischemic stimulation and further 
upregulation due to DPP4 deficiency and BIR. GLP-1R 
levels were higher in DPP4D-KIR- exendin-9-39 rats 
compared to KIR-DPP4D suggesting that exendin-9-39 
treatment resulted in a competition with GLP-1, 
Figure 2: Kidney injury scores and circulating levels of GLP-1 at different time points after acute KIR. (A–F) 
Representative H&E stained kidney sections (200×) of the 6 groups of experimental rats demonstrating higher loss of brush border in renal 
tubules (yellow arrows), tubular necrosis (green arrows), tubular dilation (red asterisk), protein cast formation (black asterisk), and dilation 
of Bowman’s capsule (blue arrows). (G) Kidney injury scores based on pathological analysis based on H&E sections of the 6 groups of 
experimental rats is shown. Note: * denotes statistical significance vs. other groups with different symbols (†, ‡, §), p < 0.0001. Scale bars in 
right lower corner represent 20 µm. (H) Baseline (day 0) circulating levels of GLP-1 in the 6 rat groups; * denotes statistical significance vs. 
†p < 0.05. (I) Circulating levels of GLP-1 in KIR-DPP4D and KIR-F344 group of rats on day 3 after KIR. * denotes statistical significance 
vs. other groups with different symbols (†, ‡), p < 0.0001; § denotes statistical significance vs. ¶p < 0.01. (J) Circulating levels of GLP-
1 at different time points in BIR-KIR-F344 animals. * denotes statistical significance vs. other groups with different symbols (†, ‡, §); 
p < 0.0001. (K) Circulating levels of GLP-1 at different time points in BIR-F344 animals. *denotes statistical significance vs. other groups 
with different symbols (†, ‡, §); p < 0.0001.
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thereby enhancing the expression of GLP-1R in kidney 
parenchyma.
Status of infiltrating inflammatory cells in 
kidney parenchyma on day 3 after acute KIR
Immunofluorescence (IF) of kidney sections showed 
low numbers of CD14+ and F4/80+ cells, two indicators 
of inflammation in SC-F344 and SC-DPP4D rats and 
gradually higher in BIR-KIR-F344, KIR-DPP4D, DPP4D-
KIR- exendin-9-39 rats and were highest in KIR-F344 rats 
(Figure 6).
Status of cellular oxidative stress and kidney 
injury on day 3 after acute KIR 
The SC-F344 and SC-DPP4D rats showed lower 
numbers of H2DCFDA+ cells in the kidney parenchyma, 
an indicator of ROS, whereas they gradually increased in 
BIR-KIR-F344, KIR-DPP4D, DPP4D-KIR- exendin-9-39 
rats and were highest in KIR-F344 rats (Figure 7). The 
expression pattern of KIM-1, a kidney injury biomarker 
that is predominantly expressed in renal tubules was 
similar to H2DCFDA in the six rat groups.
Status of podocyte, extracellular-matrix and 
renal tubule components on day 3 after acute 
KIR
Both ZO-1, a tight junction-associated protein in 
podocytes and Fibronectin, which is involved in cell-
extracellular matrix interactions were highly expressed in 
SC-F344 and SC-DPP4D rats and progressively lower in 
BIR-KIR-F344, KIR-DPP4D, DPP4D-KIR- exendin-9-39 
rats and were lowest in KIR-F344 rats (Figure 8). 
Fibronectin is situated in the mesangial and interstitial 
extracellular matrix and defective cell-extracellular matrix 
interactions contribute to ischemic renal failure [34].
Figure 3: Analysis of kidney inflammation on day 3 after acute KIR. Western blotting analysis of (A) matrix metalloproteinase-9 
(MMP-9), (B) tumor necrosis factor-α (TNF- α), (C) Nuclear factor-κB (NFκB), (D) Interleukin-1β (IL-1β), (E) Intercellular adhesion 
molecule-1 (ICAM-1), and (F) inducible nitric oxide synthase (iNOS) in the 6 groups of rats 72 h after acute KIR.  Note: *denotes statistical 
significance vs. other groups represented with different symbols (†, ‡, §, ¶), p < 0.0001.
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We then analyzed the expression of P-cadherin 
and E-cadherin by IHC, which are Ca2+-dependent cell 
adhesion molecules involved in the development and 
maintenance of renal epithelial polarity. They showed an 
identical expression pattern to ZO-1 among the six groups 
(Figure 9).
However, both FSP-1 and WT-1, which are 
predominantly expressed in kidney interstitials and 
podocytes, respectively showed opposite expression 
pattern to ZO-1 as analyzed by IHC (Figure 10).
Status of dystroglycan and podocin expression 
on day 3 after acute KIR 
We demonstrated that dystroglycan, and podocin, 
two components of podocyte foot processes, were highly 
expressed in SC-F344 and SC-DPP4D rats followed by 
progressively decreased levels in BIR-KIR-F344, KIR-
DPP4D, DPP4D-KIR- exendin-9-39 rats and were lowest 
in KIR-F344 rats (Figure 11).
DISCUSSION
In this study, we investigated the role of DPP4 in 
acute KIR injury by using DPP knockout rats. We observed 
that baseline circulating GLP-1 levels were higher in 
DPP4D rats compared to F344 rats. After KIR, GLP-1 
levels were higher in the KIR-F344 group compared to 
SC-F344, but lower compared to KIR-DPP4D and BIR-
KIR-F344 groups. This suggested that DPP4 deficiency 
and remote ischemic preconditioning protected kidneys 
against acute IR injury.
Previously, we showed that sitagliptin (DPP4 
inhibitor) or exendin-4 (GLP-1 analogue) protected 
architectural integrity of the kidneys and renal function 
during acute KIR injury [14, 15]. However, the role of 
DPP4 during acute kidney IR injury was not directly 
investigated, especially in regard to GLP-1 [14, 15]. In this 
study, we showed that the circulating levels of creatinine 
and BUN and urine protein to creatinine ratio and 
anatomical/histopathological injury (H&E, IHC and IF 
showing kidney morphology and kidney injury score) were 
substantially higher in KIR-F344 animals than in SC-F344 
animals, but reduced in KIR-DPP4D animals. This 
corroborated our previous findings that DPP4 influenced 
the extent of kidney damage during IR injury [14, 15]. 
These findings highlight the therapeutic potential of 
the DPP4 inhibitors and GLP-1 analogues during AKI, 
especially in type 2 DM patients.
Remote ischemic preconditioning has been shown 
to protect other organs/tissues from IR injury [29–31]. 
Remote ischemic preconditioning involves complex 
signaling and interactions that activate ATP-dependent 
potassium channels, adenosine and PKC, release 
Figure 4: Analysis of apoptotic, DNA damage and oxidative stress in the kidney on day 3 after acute KIR. Western 
blot analysis of (A) cleaved caspase 3 (c-Casp3), (B) cleaved caspase 3 (c-Casp3), (C) cleaved Poly (ADP-ribose) polymerase (c-PARP), 
(D) γ-H2AX, (E) NOX-1 and (F) total oxidized protein by oxyblot (left most lanes in the upper panel represent protein molecular weight 
marker and control oxidized molecular protein standard, respectively; DNP is 1-3 dinitrophenylhydrazone) in the 6 groups of rats 72 h after 
acute KIR. Note *denotes statistical significance vs. other groups represented with different symbols (†, ‡, §, ¶), p < 0.0001.
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autacoids such as adenosine and bradykinin, generate 
neurohormones, nitric oxide and chemokines (such as 
hypoxia-inducible factor-1α), open mitochondrial K+-
ATP-channels and elicit GSK3β and STAT-3 signaling 
that attenuate opening of the mitochondrial permeability 
transition pore [29–31]. In this study, we show that 
remote ischemic preconditioning by small BIR protects 
kidneys against acute KIR injury. The renal function and 
kidney architectural integrity was better preserved in BIR-
KIR-F344 rats compared to KIR-DPP4D rats.
The signal transduction pathways in ischemic pre-, 
post-, and remote conditioning that protect tissues/organs 
against acute IR are highly complex [30]. In the present 
study, circulating GLP-1 levels were higher in BIR-
KIR-F344 animals at 3 to 6 hrs after acute KIR compared 
to the KIR-F344 group.  Also, the circulating GLP-1 levels 
increased rapidly during the acute phase in BIR-KIR-F344 
rats suggesting that the gastrointestinal-digestive tract 
was a major source of GLP-1 in response to ischemic 
stimulation as previously suggested [30].
Figure 5: Analysis of podocyte components, antioxidants and GLP-R on day 3 after acute KIR. Western blot analysis of 
(A) ZO-1, (B) P-cadherin (C) E-cadherin (D) eNOS, (F) NQO1, (G) heme oxygenase 1 (HO-1), (H) SOD-1 and (I) glucagon like peptide 
receptor (GLP-R) in the 6 groups of rats 72 h after acute KIR. *denotes statistical significance vs. other groups represented with different 
symbols (†, ‡, §, ¶), p < 0.0001.
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Numerous studies have demonstrated that AKI or acute 
KIR injury generates oxidative stress and reactive oxygen 
species [13–15], elicits cellular apoptosis [11, 13–15], and 
activates complement and inflammation [10–14, 27]. These 
factors damage the kidney function and its anatomical 
structure [13–15, 35]. In our study, the acute KIR rats showed 
increased inflammation, oxidative stress, DNA damage and 
apoptosis consistent with previous studies [10–15]. The 
extent of functional and architectural damage to the kidneys 
in KIR-F344 rats was significantly higher compared to SC-
F344, but lower in KIR-DPP4D and BIR-KIR-F344 rats.  
In a previous study, we demonstrated that acute KIR 
substantial damaged the kidney ultrastructure [15]. In this 
study, we confirmed that KIR substantially damaged the 
kidney ultrastructural integrity (components of podocyte 
foot process in glomeruli, renal tubule and extracellular 
matrix) in KIR-F344 rats compared to SC-F344 animals, 
but was better preserved in KIR-DPP4D and BIR-
KIR-F344 rats. This suggested that DPP4 deficiency and 
remote ischemic preconditioning preserved renal function 
during acute kidney injury. 
We also demonstrated increased expression of 
antioxidant proteins like NQO 1, HO-1 and SOD-1 and 
GLP-1 receptor in the kidney tissues of KIR-DPP4D 
and BIR-KIR-F344 rats compared to the sham controls 
and KIR-F344 rats. These findings suggested that DPP4 
deficiency and remote ischemic preconditioning protected 
kidneys from the damage by ischemic stimulation and 
Figure 6: Analysis of infiltration of inflammatory cells in kidney parenchyma on day 3 after acute KIR. (A–F) 
Representative immunofluorescence (IF) images (400x) showing CD14+ cells (green color) in the kidney parenchyma in the 6 groups of 
rats 72 h after acute KIR. (G) Quantification of mean total number of CD14+ cells in the kidney sections from 6 groups of rats, 72 h after 
acute KIR. (H–M) Representative IF images (400×) showing F4/80+ cells (green color) in kidney parenchyma in the 6 groups of rats 72 h 
after acute KIR. (N) Quantification of mean total number of F4/80+ cells in the kidney sections from 6 groups of rats, 72 h after acute KIR. 
Note: *denotes statistical significance vs. other groups represented with different symbols (†, ‡, §, ¶), p < 0.0001. Scale bars in the right 
lower corner represent 20 µm. Blue color indicates nuclei were stained by DAPI.
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IR injury. These findings support and improve our 
understanding of mechanisms that enable protective 
ischemic conditioning against acute IR injury in tissues/
organs [30]. 
This study has limitations that need to be 
highlighted. First, the study period was only 72 h and 
therefore long term impact of DPP4 deficiency and remote 
ischemic preconditioning were not addressed. Second, 
although the small BIR procedure was used to elicit remote 
ischemic preconditioning in rats and shown to protect the 
kidneys from IR injury, such a method is not currently 
feasible for human patients. Third, although we identified 
changes in many signaling and functional entities in 
response to acute kidney injury as well as their status 
in DPP4 deficient or remote ischemic preconditioning 
conditions, the exact interplay of the various pathways and 
their relationship to renal oxidative stress, inflammation or 
cellular apoptosis are still not clear. Figure 12 summarizes 
probable protective mechanisms in the DPP4D rat kidneys 
and remote ischemic preconditioning against acute KIR. 
Fourth, although BIR was comparable to DPP4 deficiency 
in protecting the kidney from acute IR injury, it wasn’t 
clear if increased GLP-1 mediated the protective effects 
of BIR.
In conclusion, our study demonstrates that DPP4 
deficiency and remote ischemic preconditioning protect 
kidneys from acute IR injury by elevating circulating 
GLP-1 levels and represent potential therapeutic targets 
Figure 7: Analysis of cellular oxidative stress and kidney injury markers on day 3 after acute KIR. (A–F) Representative 
IF images (200×) showing H2DCFDA+ cells (red color) in the kidney parenchyma of the 6 groups of rats, 72 h after acute KIR. (G) 
Quantification of total number of H2DCFDA+ cells in the kidney sections from 6 groups of rats, 72 h after acute KIR. *denotes statistical 
significance vs. other groups represented with different symbols (†, ‡, §, ¶), p < 0.0001. Scale bars in right lower corner represent 50 µm. 
(H–M) Representative IF images (400×) showing KIM+- cells (green color). (N) Quantification of mean total number of KIM+ cells in 
the kidney sections from 6 groups of rats, 72 h after acute KIR. *denotes statistical significance vs. other groups represented with different 
symbols (†, ‡, §, ¶), p < 0.0001. Scale bars in right lower corner represent 20 µm. Blue color indicates DAPI stained nuclei.
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for acute kidney injury, especially in type 2 diabetic 
patients.
MATERIALS AND METHODS
Experimental animals
The animal experiments were conducted according 
to approved protocols by the Animal Care and Use 
Committee at Kaohsiung Chang Gung Memorial Hospital 
(Affidavit of Approval of Animal Use Protocol No. 
2015032402) and executed according to the Guide for the 
Care and Use of Laboratory Animals, 8th edition (NRC 
2011). Pathogen-free, adult male (n = 32) and dipeptidyl 
peptidase 4 (DPP4) mutant (n = 16) Fischer 344 rats 
weighing 300–320 g were obtained from Charles River 
Technology (BioLASCO Taiwan Co. Ltd., Taiwan). The 
animals were housed in an AAALAC-approved animal 
facility in our hospital with controlled temperature and 
light cycles (24°C and 12/12 h light/dark cycles).
Acute kidney ischemia-reperfusion (IR) protocol 
and animal grouping
The acute kidney IR was performed according to 
previously published protocol [15, 35]. Briefly, animals 
were anesthetized with 2% isoflurane and placed supine 
on a warming pad at 37°C for midline laparotomies. 
Figure 8: Immunofluorescence (IF) analysis of ZO-1 and fibronectin expression on day 3 after acute KIR. (A–F) 
Representative IF images (400×) showing positively stained ZO-1 (green color) distribution in glomeruli of the 6 groups of rats, 72 h 
after acute KIR. (G) Quantification of total number of ZO-1 positive cells in the kidneys of 6 groups of rats, 72 h after acute KIR. (H–M) 
Representative IF images (400×) showing positively stained fibronectin (green color) distribution in extracellular matrix of 6 groups of rats, 
72 h after acute KIR. (N) Quantification of total number of fibronectin positive cells in kidneys of the 6 groups of rats, 72 h after acute KIR. 
*denotes statistical significance vs. other groups represented with different symbols (†, ‡, §, ¶), p < 0.0001. Scale bars in right lower corner 
represent 20 µm. Blue color indicates DAPI stained nuclei.
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The sham control (SC) animals underwent laparotomy 
only.  Acute IR injury of both kidneys was induced by 
clamping the renal pedicles of the rats with non-traumatic 
vascular clips for 60 minutes followed by reperfusion for 
72 h. The animals were then euthanized and the kidneys 
were harvested for further experiments. Left kidney was 
used for H&E staining, immunofluorescence (IF) and 
immunohistochemistry (IHC) and the right kidney was 
used for western blotting.
The rats were categorized into six groups (n = 8 
group): (1) sham control F344 (SC-F344) with laparotomy 
without kidney IR (KIR); (2) sham control DPP4 mutant 
rats (SC-DPP4D); (3) kidney IR in F344 rats (KIR-F344); 
(4) kidney IR in DPP4 mutant rats (KIR-DPP4D); (5) 
KIR-DPP4D with intraperitoneal injection of 10 mg/kg 
exendin-9-39 at 30 minutes and days 1–3 after KIR; 
and (6) small bowel IR in F344 rats with KIR (BIR-
KIR-F344). Exendin-9-39 is an antagonist of exendin 4, a 
hypoglycemic agent and a GLP-1 analog used for type II 
diabetes mellitus. The dosage of exendin-9-39 was based 
on our previous study [14].
Remote ischemic preconditioning by intermittent 
small bowel IR 
The small bowel IR injury was performed according 
to previously published protocol [36]. Briefly, the small 
BIR injury in group 6 rats involved clamping the superior 
Figure 9: Immunohistochemical (IHC) analysis of P-cadherin and E-cadherin expression on day 3 after acute KIR. 
(A–F) Representative IHC images (200×) showing positively stained P-cadherin (gray color) distribution in renal tubules of the 6 groups 
of rats, 72 h after acute KIR. (G) Quantification of total number of P-cadherin positive cells in the kidney sections from 6 groups of rats, 
72 h after acute KIR injury. (H–M) Representative IHC images (200×) showing positively stained E-cadherin (gray color) distribution in 
extracellular matrix of 6 groups of rats, 72 h after acute KIR. (N) Quantification of total number of E-cadherin positive stained cells in the 
kidney sections from 6 groups of rats, 72 h after acute KIR. *denotes statistical significance vs. other groups represented with different 
symbols (†, ‡, §, ¶), p < 0.0001. Scale bars in right lower corner represent 50 µm in the kidney sections from 6 groups of rats, 72 h after 
acute KIR injury.
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mesenteric artery for 5 mins followed by reperfusion for 
5 mins and repeating the procedure 6 times. The acute 
kidney IR procedure was performed immediately after 
finishing the small BIR procedure.
Estimating kidney injury scores after acute KIR 
Histopathology scoring was performed on kidney 
samples isolated on day 3 after KIR and were assessed 
blind as previously described [13–15]. Briefly, the kidney 
specimens were fixed in 10% buffered formalin and 
embedded in paraffin. Then, 5 μm sections were cut and 
stained with hematoxylin and eosin (H&E) and observed 
by light microscopy. The scoring system involved grading 
the extent of tubular necrosis, loss of brush border, cast 
formation and tubular dilation in 10 randomly chosen 
non-overlapping fields (200×) for each rat kidney sample 
[32]. The scores were 0 (0%), 1 (≤ 10%), 2 (11–25%), 
3 (26–45%), 4 (46–75%), and 5 (≥ 76%).
Estimation of blood urea nitrogen and creatinine 
and urine protein to creatinine ratio after acute 
KIR 
Blood samples were collected from the rats in all 
6 groups before and 72 h after IR to measure changes in 
serum creatinine and urea nitrogen.
To determine the ratio of urine protein to creatinine, 
each animal was placed in a metabolic cage (DXL-D, 
190 mm × 290 mm × 550 mm, Suzhou Fengshi Laboratory 
Figure 10: Immunohistochemical (IHC) analysis of FSP-1 and WT-1 expression on day 3 after acute KIR. (A–F) 
Representative IHC images (200×) showing positively stained fibroblast specific protein-1 (FSP-1) (gray color) distribution in kidney 
interstitials from 6 groups of rats, 72 h after acute KIR injury. (G) Quantification of total number of FSP-1 positive cells in the kidney 
sections from 6 groups of rats, 72 h after acute KIR. (H–M) Representative IHC images (200×) for positively stained Wilm’s tumor 
suppressor gene1 (WT-1) (gray color) in podocytes from 6 groups of rats, 72 h after acute KIR. (N) Quantification of total number of WT-1 
positive cells in the kidney sections from 6 groups of rats, 72 h after acute KIR. *denotes statistical significance vs. other groups represented 
with different symbols (†, ‡, §, ¶), p < 0.0001. Scale bars in right lower corner represent 50 µm.
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Animal Equipment Co. Ltd., Mainland China) for 24 h 
with free access to food and water. Urine was collected for 
24 h before and 72 h after IR.
IHC and IF staining 
The IHC and IF staining was performed according 
to previously published protocols [13–15]. For IHC and 
IF staining, rehydrated paraffin sections were treated 
with 3% H
2
O
2
 for 30 minutes and then incubated with 
Immuno-Block reagent (BioSB, Santa Barbara, CA, USA) 
for 30 minutes at room temperature. Then, the sections 
were incubated with the following primary antibodies: 
zonula occludens-1 (ZO-1; 1:300, Abcam, Cambridge, 
MA, USA), Wilm’s tumor suppressor gene 1 (WT-1; 
1:1000, Abcam, Cambridge, MA, USA), kidney injury 
molecule (KIM-1;1:200, R&D systems, Minneapolis, MN, 
USA), fibroblast specific protein (FSP-1; 1:200, Abcam, 
Cambridge, MA, USA), P-cadherin (1:100, Novus, 
Littleton, CO, USA), podocin (1:100,Sigma, St. Louis, 
Mo, USA), dystrophin (1:100, Abcam, Cambridge, MA, 
USA), fibronectin (1:200, Abcam, Cambridge, MA, USA), 
dystroglycan (1:50, Abcam, Cambridge, MA, USA), 
synaptopodin (1:100, Santa Cruz, CA, USA), CD14 (1:50, 
Santa Cruz, CA, USA), CD68 (1:100, Abcam, Cambridge, 
MA, USA); sections incubated with irrelevant antibodies 
served as controls. Three kidney sections were analyzed 
from each rat. For quantification, three randomly selected 
high power fields (HPFs; 200× for IHC; 400× for IF) were 
analyzed in each section. The mean number of positively-
Figure 11: IHC analysis of dystroglycan and podocin on day 3 after acute KIR. (A–F) Representative IHC images (400×) for 
positively stained dystroglycan (gray color) in podocyte foot process from 6 groups of rats, 72 h after acute KIR. (G) Quantification of total 
number of dystroglycan positive cells. (H–M) Representative IHC images (200×) for positively stained podocin (gray color) in podocytes 
from 6 groups of rats, 72 h after acute KIR. (N) Quantification of total number of podocin positive cells in kidney sections from 6 groups 
of rats, 72 h after acute KIR. *denotes statistical significance vs. other groups represented with different symbols (†, ‡, §, ¶), p < 0.0001. 
Scale bars in right lower corner represent 50 µm.
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stained cells per HPF for each animal was determined by 
summation of all numbers divided by 9.
Western blot analysis
Western blot analysis was performed according 
to previous published protocols [13–15]. Briefly, 
50 µg of total kidney protein extract from different 
groups of rats were separated by SDS-PAGE using 
acrylamide gradients. Then, the separated proteins 
were transferred electrophoretically to a polyvinylidene 
difluoride (PVDF) membrane (Amersham Biosciences, 
Amersham, UK). Non-specific binding was blocked 
by incubating the membrane in 5% nonfat dry milk in 
T-TBS (TBS containing 0.05% Tween 20) overnight. 
Then, the membranes were incubated for 1h at room 
temperature with primary antibodies against matrix 
metalloproteinase (MMP-9; 1:3000, Abcam, Cambridge, 
MA, USA), tumor necrosis factor (TNF-α; 1:1000, Cell 
Signaling, Danvers, MA, USA), nuclear factor (NF-κB; 
1:600, Abcam, Cambridge, MA, USA), interleukin 
(IL-1β; 1:1000, Cell Signaling, Danvers, MA, USA), 
intercellular adhesion molecule (ICAM-1; 1:1000, Abcam, 
Cambridge, MA, USA), inducible nitric oxide synthase 
(iNOS; 1:200, Abcam, Cambridge, MA, USA), cleaved 
caspase 3 (1:1000, Cell Signaling, Danvers, MA, USA), 
cleaved PolyADP-ribosepolymerase (c-PARP; 1:1000, 
Cell Signaling, Danvers, MA, USA), mitochondrial 
Bax (1:1000, Abcam, Cambridge, MA, USA), γ-H2AX 
(1:1000, Cell Signaling, Danvers, MA, USA), endothelial 
nitric oxide synthase (eNOS; 1:1000, Abcam, Cambridge, 
MA, USA), heme oxygenase-1 (HO-1; 1:500, Cell 
Signaling, Danvers, MA, USA), glucagon like peptide 
1 receptor (GLP-1R; 1:1000, Abcam, Cambridge, MA, 
USA), superoxide dismutase (SOD; 1:2000, Abcam, 
Cambridge, MA, USA), NAD(P)H dehydrogenasequinone 
Figure 12: Proposed mechanisms underlying the positive therapeutic effects of DPP4 deficiency and small bowel 
ischemia-reperfusion (IR) preconditioning against acute kidney IR injury. GLP-1 = glucagon like peptide 1; DDP4 = dipeptidyl 
peptidase 4 deficiency; MMP = matrix metalloproteinase; TNF = tumor necrosis factor; NF = nuclear factor; IL = interleukin; ICAM = 
intercellular adhesion molecule; iNOS = inducible nitric oxide synthase; mito = mitochondrial; c-Casp = cleaved caspase 3; c-PARP = 
cleaved protein expression of Poly (ADP-ribose) polymerase; HO = heme oxygenase; NQO 1 = NAD(P)H quinone dehydrogenase 1; 
eNOS = endothelial nitric oxide synthase; KIM = kidney injury molecule; WT-1 = Wilm’s tumor suppressor gene 1;  FSP-1 = fibroblast 
specific protein 1; BUN = blood urea nitrogen.
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1 (NQO 1; 1:1000, Abcam, Cambridge, MA, USA), 
NOX-1 (1:1500, Sigma, St. Louis, Mo, USA), NOX-2 
(1:750, Sigma, St. Louis, Mo, USA), and actin (1: 10000, 
Chemicon, Billerica, MA, USA). Horseradish peroxidase-
conjugated anti-rabbit immunoglobulin IgG (1:2000, Cell 
Signaling, Danvers, MA, USA) was used as a secondary 
antibody for 1h at room temperature.  Then, after washing, 
the blots were developed and visualized by enhanced 
chemiluminescence (ECL; Amersham Biosciences, 
Amersham, UK) and exposed to Biomax L film (Kodak, 
Rochester, NY, USA). ECL signals were quantitated using 
Labwork software (UVP, Waltham, MA, USA).
Oxyblot oxidized protein detection 
Oxidative stress was assessed according to 
previously published protocols [13–15] using the 
Oxyblot Oxidized Protein Detection Kit (S7150, 
Chemicon, Billerica, MA). First, we DNPH derivatized 
6 μg total rat kidney protein for 15 minutes according 
to the manufacturer’s instructions. Then, the DNPH 
derivatized proteins were electrophoresed on a 12% 
SDS-PAGE followed by electrophoretic transfer of 
proteins to nitrocellulose membranes. After blocking, 
the membranes were incubated with primary anti-DNP1 
antibody (1:150) for 2 h followed by incubation with 
secondary antibody (1:300) for 1 h at room temperature. 
After washing repeatedly, the blots were developed 
and visualized by enhanced chemiluminescence (ECL; 
Amersham Biosciences, Amersham, UK) and exposed to 
Biomax L film (Kodak, Rochester, NY, USA). ECL signals 
were quantified using Labwork software (UVP, Waltham, 
MA, USA). A standard control was loaded on each gel as 
reference for oxyblot protein analysis.
Assessment of ROS by H2DCFDA 
We assessed reactive oxygen species (ROS) 
according to previously published protocols [34]. 
Thirty minutes prior to the end of the study, the rats 
were anesthetized with 2% isoflurane and intravenously 
administered 150 µg of CM-H2DCFDA (Life Technologies 
Molecular Probes; 100 μg of H2DCFDA was dissolved in 
200 µl PBS). After 30 minutes, the kidneys were harvested 
and immediately frozen in liquid nitrogen. Then, 5 μm 
thick cryostat sections were cut at −20°C and the serial 
frozen sections were fixed with 4% paraformaldehyde 
in phosphate buffered saline at 4°C for 5 minutes. After 
washing the sections with PBS, they were co-stained with 
DAPI and analyzed by fluorescence microscopy.
All sections were examined under a fluorescent 
microscope (200×). The fluorescence and gray photos 
were assessed by DP controller 2.1.1.183 (Olympus). The 
gray photos were used to measure fluorescence intensity 
with Image J 1.37v (National Institutes of Health, USA). 
Three gray photos from three sections were randomly 
analyzed for each animal. The baseline fluorescence 
intensity (BFI) [arbitrary unit/200 × high-power field 
(HPF)] was determined by comparing the area of increased 
fluorescence intensity (IFI) with the area in the kidney 
without H
2
DCFDA. Six BFI areas were measured from 
each gray photo. The mean IFI and BFI were calculated 
from three randomly chosen BFI areas. The relative 
fluorescence intensity was determined from the ratio of 
IFI to BFI.
Statistical analysis
Quantitative data was expressed as mean ± SD. 
Statistical analysis was performed by ANOVA followed 
by Bonferroni multiple-comparison post hoc test with 
the SAS statistical software for Windows version 8.2 
(SAS institute, Cary, NC). A P < 0.05 was considered 
statistically significant.
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